New Zealand markets closed

Rani Therapeutics Holdings, Inc. (RANI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.50+0.38 (+7.42%)
At close: 04:00PM EDT
5.31 -0.19 (-3.45%)
After hours: 06:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
2,717
462
-
Operating expenses
Research development
37,498
39,624
36,607
26,482
12,044
-
Selling general and administrative
26,119
26,475
26,844
27,834
4,962
-
Total operating expenses
63,617
66,099
63,451
54,316
17,006
-
Operating income or loss
-63,617
-66,099
-63,451
-51,599
-16,544
-
Interest expense
5,172
5,085
1,071
466
124
-
Total other income/expenses net
-
-
-
-1,071
-63
65
Income before tax
-65,830
-67,883
-63,274
-53,047
-16,668
-
Income tax expense
-
0
70
41
35
-
Income from continuing operations
-65,830
-67,883
-63,344
-53,088
-16,703
-
Net income
-33,081
-33,970
-30,588
-8,331
0
-
Net income available to common shareholders
-33,081
-33,970
-30,588
-8,331
0
-
Basic EPS
-1.41
-
-1.28
-0.43
0.00
-1.42
Diluted EPS
-1.41
-
-1.28
-0.43
0.00
-1.42
Basic average shares
25,265
-
23,817
19,534
18,739
18,739
Diluted average shares
25,265
-
23,817
19,534
18,739
18,739